2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$0.90-$0.03 (-3.10%)
Price as of Nov 11, 2026 7:47 PM EST- $322.9MMarket Cap
- -24.85%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$0.90-$0.03 (-3.10%)
ALLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.93 | ||
Change | -$0.13 (-12.08%) | ||
Open | $1.04 | ||
High | $1.04 | ||
Low | $0.89 | ||
Previous Close | $1.06 | ||
Volume | 22,865,139 | ||
30-Day Average Volume | 10,011,071 | ||
1-Week Change | -16.79% | ||
1-Month Change | -36.17% | ||
1-Year Change | -24.85% | ||
3-Year Change | -62.72% | ||
5-Year Change | -95.08% | ||
Fundamentals | |||
Shares Outstanding | 346.5M | ||
Total Assets | $511.3M | ||
Market Cap | $322.9M | ||
Enterprise Value | $293.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$50.4M | ||
Free Cash Flow | -$36.1M | ||
EBIT | -$50.4M | ||
EBITDA | -$47.8M | ||
Net Working Capital | $261.3M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue